Ukraine has been one of the major markets for Macleods for over a decade. We set up operations in this region in 2005 and have since focussed on multiple therapy areas. We also develop infusion solutions and drugs for the Ukraine market, to treat ailments such as tuberculosis, influenza, and HIV/ AIDS.

Through our years of operations in Ukraine, we have always remained committed to developing and supporting the country’s healthcare facilities.

At Macleods Pharmaceuticals Ukraine, we exercise a zero-tolerance policy against racial, age and gender bias. Ours is an inclusive culture, which gives job opportunities to people from across the country. We offer the advantage of competitive salaries and an attractive social package, along with the highest standards of a corporate culture.

We believe in empowering all our people with appropriate training and facilities; not just those with a sound professional background and work experience, but also university graduates and freshers who are looking to kickstart their career in the pharma industry.

In the context of the COVID-19 pandemic, we guarantee the utmost safety of all our people.

Given the unprecedented nature of the COVID-19 pandemic and its severe effects on health and business, we at Macleods Ukraine are doing all that we can to support doctors and patients and the healthcare system in the country by making vital medicines available. Likewise, we are also responsible for the wellbeing of our employees and are responsible for their safety.

While continuing to closely monitor the development of events in Ukraine, we have also introduced several quarantine measures for our employees in line with the recommendations of state bodies. Our employees have also been provided with medical insurance that will cover their costs, in case of any unforeseen events related to the pandemic.